Healthcare pricing transparency is a powerful but underused tool for employers to reduce costs. It means making clear, accessible information about prices available before a purchase or claim occurs: the cost of medical services, procedures, drugs, and insurance premiums. For employers, this shift from opaque, negotiated rates to visible, competitive pricing affects the bottom line through better plan design, smarter purchasing, and improved employee engagement.
How Pricing Transparency Directly Lowers Employer Costs
Without transparency, employers and their employees often pay vastly different amounts for the same service, even within the same network. RAND's hospital price transparency study found that in 2022 employers and private insurers paid, on average, 254% of what Medicare would have paid for the same services at the same facilities. That gap leaves room for high-cost providers and wasteful spending to thrive. These are the main ways transparency pulls employer costs down:
- Enables Reference-Based Pricing (RBP): Transparency lets employers benchmark costs against a standard such as Medicare rates. With actual prices disclosed, employers can design plans that pay a fixed maximum for a procedure, pushing employees toward cost-efficient providers or leaving them to cover the difference. This cuts wasteful spending on overpriced facilities.
- Empowers Employee Shopping: When employees can see the price of an MRI, knee replacement, or prescription drug across providers, they can choose lower-cost, high-quality options. Employers can add incentives such as lower copays or deductibles for efficient providers. The spreads are real: a Health Care Cost Institute analysis found an MRI of the lower back ranged from about $300 at one facility to more than $3,000 at another, a difference shared between the employee and the plan.
- Reduces Hidden Markups in Pharmacy Benefits: Pharmacy benefit manager (PBM) contracts are notoriously opaque. Transparency exposes the difference between what the PBM pays a pharmacy and what it charges the employer, known as the spread. Employers can then negotiate cleaner PBM contracts, drop spread pricing, and move to pass-through models that lower drug costs.
- Improves Network Negotiation: Armed with data on what hospitals and physician groups actually charge, employers can negotiate harder in-network discounts, flag out-of-network providers with excessive rates, and either exclude them or contract directly at fair, visible prices.
- Lowers Administrative Waste: Opaque pricing feeds billing errors, denials, and disputes that consume legal and administrative resources. Clear prices at the point of service reduce the need for post-claim correction.
Case in Point: CalPERS Reference Pricing for Joint Replacement
The California Public Employees' Retirement System (CalPERS) tested this on hip and knee replacements. In 2011, CalPERS set a reference price for the procedures: the plan would pay up to a fixed amount, members would cover anything above it, and members could still choose any facility. Prices at high-price facilities then fell 18%, and a Health Affairs study attributed $2.8 million in joint-replacement savings to the program in 2011 alone. Patient volumes shifted from high-price to low-price facilities with no change in complication rates. Researchers at UC Berkeley's Center for Health Technology report the program also saved $1.3 million on cataract surgery and $2.3 million on arthroscopy over two years.
Key Compliance and Implementation Considerations
Putting transparency into practice has compliance and data challenges. Employers need to watch several areas:
- Compliance with the Transparency in Coverage (TiC) rule: The federal TiC rule requires non-grandfathered group health plans to post machine-readable files showing negotiated in-network rates for all covered items and services, plus out-of-network allowed amounts. Plans have had to publish these files monthly since July 1, 2022. Employers still need to work with carriers and TPAs to keep the files accurate and complete.
- Data integrity and usability: Raw price data does employees no good if they can't read it. Employers need tools that combine price, quality measures (such as HEDIS or AHRQ quality indicators), and patient reviews. Poor integration confuses employees and erodes trust. Regulators have heard the same complaint: a proposed rule published in December 2025 would shrink the machine-readable files and add context, targeting the bulk and ambiguity employers hit today.
- Network access and quality parity: Lower cost can't come at the expense of quality. Transparent pricing tools need to reflect clinical outcomes, because a cheap surgery with high complication rates is not a savings.
- Legal protections for plan fiduciaries: Under ERISA, plan fiduciaries must act prudently. Steering members toward lower-cost providers without evidence of quality can invite legal scrutiny, so solid outcome and patient-satisfaction data is essential.
Transparency as a Fiduciary Duty
Transparency stopped being optional for employer health plans in 2021. The Consolidated Appropriations Act, 2021 amended ERISA section 408(b)(2) to require brokers and consultants working with group health plans to disclose their direct and indirect compensation, and it puts fiduciaries on the hook to decide whether that compensation is reasonable. An employer that signs an opaque contract without knowing what the middlemen are paid is taking on legal risk.
The exposure is already showing up in court. Law-firm commentary in early 2024 described group health plans as a new front for ERISA fee litigation, and at least one class action had been filed by February 2024 over group health plan fees. For employers, the practical lesson is that price data is a risk-management tool as much as a savings tool. Documenting that you reviewed costs and service-provider compensation is part of acting prudently.
The Bottom Line for Employers
Transparency in pricing is a strategic shift rather than a one-time fix. It moves healthcare purchasing from a blind, fee-for-service model to an informed, value-based one. Employers who use price data alongside quality measures can cut what they pay for targeted procedures: after CalPERS capped what it would pay for hip and knee replacements, prices at high-price facilities fell 18%. Dropping PBM spread pricing lowers drug spend, and consumer-driven plan designs steer members to better choices. Transparency is foundational to a sustainable, cost-effective employer health strategy.
Transparency is the operating principle WellthCare™ builds on. Employees get $0-co-pay care that is used before the primary plan, which removes surprise billing at the point of service. The program's cost-management capabilities include medical bill review and cost transparency tools, and its pharmacy approach eliminates spread pricing. See what a WellthCare Plan would look like for your team.
This article is for general information only and is not legal, tax, or medical advice. Employers should consult their own advisors.